Compile Data Set for Download or QSAR
Report error Found 100 Enz. Inhib. hit(s) with all data for entry = 10077
TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512342BDBM512342(Preparation of 2-chloro-N-(4-fluoro-3-((2-((1-(tet...)
Affinity DataIC50: 0.5nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512334BDBM512334(Preparation of N-(4-fluoro-3-((2-((1-(tetrahydro-2...)
Affinity DataIC50: 0.5nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512305BDBM512305(Preparation of N-(3-((2-((1-ethyl-1H-pyrazol-4-yl)...)
Affinity DataIC50: 0.5nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512306BDBM512306(Preparation of N-(4-fluoro-3-((2-((3-methylisothia...)
Affinity DataIC50: 0.5nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512302BDBM512302(Preparation of N-(3-((2-((1-methyl-1H-pyrazol-4-yl...)
Affinity DataIC50: 0.600nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512304BDBM512304(Preparation of N-(3-((2-((3-methylisothiazol-5-yl)...)
Affinity DataIC50: 0.600nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512307BDBM512307(Preparation of N-(3-((2-((1-ethyl-1H-pyrazol-4-yl)...)
Affinity DataIC50: 0.600nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512341BDBM512341(Preparation of 2-chloro-N-(3-((2-((1-(2,2-difluoro...)
Affinity DataIC50: 0.700nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512327BDBM512327(Preparation of N-(4-fluoro-3-((2-((1-methyl-1H-pyr...)
Affinity DataIC50: 0.700nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512343BDBM512343(Preparation of 2-chloro-N-(3-((2-((1-ethyl-1H-pyra...)
Affinity DataIC50: 0.700nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512335BDBM512335(Preparation of N-(4-fluoro-3-((2-((1-(2-morpholino...)
Affinity DataIC50: 0.700nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512311BDBM512311(Preparation of N-(3-((2-((4-(dimethylamino)phenyl)...)
Affinity DataIC50: 0.700nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512303BDBM512303(Preparation of N-(3-((2-((1-(2,2-difluoroethyl)-1H...)
Affinity DataIC50: 0.700nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512326BDBM512326(Preparation of N-(3-((2-((1-(2,2-difluoroethyl)-1H...)
Affinity DataIC50: 0.900nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512299BDBM512299(Preparation of N-(3-((2-((1-cyclopropyl-1H-pyrazol...)
Affinity DataIC50: 1.10nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512336BDBM512336(Preparation of N-(4-fluoro-3-((2-((1-isopropyl-1H-...)
Affinity DataIC50: 1.10nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512341BDBM512341(Preparation of 2-chloro-N-(3-((2-((1-(2,2-difluoro...)
Affinity DataIC50: 1.20nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512343BDBM512343(Preparation of 2-chloro-N-(3-((2-((1-ethyl-1H-pyra...)
Affinity DataIC50: 1.20nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512342BDBM512342(Preparation of 2-chloro-N-(4-fluoro-3-((2-((1-(tet...)
Affinity DataIC50: 1.30nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512325BDBM512325(Preparation of N-(4-fluoro-3-((2-((4-(4-methylpipe...)
Affinity DataIC50: 1.40nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512332BDBM512332(Preparation of N-(4-fluoro-3-((2-((1-propyl-1H-pyr...)
Affinity DataIC50: 1.40nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 50357312BDBM50357312(IBRUTINIB | US9181263, 1 | US9108973, Ref 1 | US92...)
Affinity DataIC50: 1.60nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512338BDBM512338(Preparation of N-(4-fluoro-3-((2-((1-(2,2,2-triflu...)
Affinity DataIC50: 1.80nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512329BDBM512329(Preparation of N-(4-fluoro-3-((2-((4-(morpholine-4...)
Affinity DataIC50: 2nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512317BDBM512317(US11084823, Example 18)
Affinity DataIC50: 2.20nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 50193995BDBM50193995(CP-690550 | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrro...)
Affinity DataIC50: 2.20nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512334BDBM512334(Preparation of N-(4-fluoro-3-((2-((1-(tetrahydro-2...)
Affinity DataIC50: 2.40nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512333BDBM512333(Preparation of N-(3-((2-((1-(difluoromethyl)-1H-py...)
Affinity DataIC50: 2.80nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512300BDBM512300(US11084823, Example 2)
Affinity DataIC50: 2.80nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512340BDBM512340(Preparation of N-(4-fluoro-3-((2-((1-(2-methoxyeth...)
Affinity DataIC50: 2.80nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512335BDBM512335(Preparation of N-(4-fluoro-3-((2-((1-(2-morpholino...)
Affinity DataIC50: 3.5nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512336BDBM512336(Preparation of N-(4-fluoro-3-((2-((1-isopropyl-1H-...)
Affinity DataIC50: 4.40nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512331BDBM512331(Preparation of N-(4-fluoro-3-((2-((4-morpholinophe...)
Affinity DataIC50: 4.5nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512327BDBM512327(Preparation of N-(4-fluoro-3-((2-((1-methyl-1H-pyr...)
Affinity DataIC50: 5nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512318BDBM512318(US11084823, Example 19)
Affinity DataIC50: 5.30nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512322BDBM512322(US11084823, Example 22)
Affinity DataIC50: 5.30nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512316BDBM512316(US11084823, Example 17)
Affinity DataIC50: 5.90nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512326BDBM512326(Preparation of N-(3-((2-((1-(2,2-difluoroethyl)-1H...)
Affinity DataIC50: 6.20nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512311BDBM512311(Preparation of N-(3-((2-((4-(dimethylamino)phenyl)...)
Affinity DataIC50: 7.5nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512330BDBM512330(Preparation of N-(4-fluoro-3-((2-((thiophen-3-yl)a...)
Affinity DataIC50: 7.60nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512307BDBM512307(Preparation of N-(3-((2-((1-ethyl-1H-pyrazol-4-yl)...)
Affinity DataIC50: 7.70nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512325BDBM512325(Preparation of N-(4-fluoro-3-((2-((4-(4-methylpipe...)
Affinity DataIC50: 7.90nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512304BDBM512304(Preparation of N-(3-((2-((3-methylisothiazol-5-yl)...)
Affinity DataIC50: 8.70nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512332BDBM512332(Preparation of N-(4-fluoro-3-((2-((1-propyl-1H-pyr...)
Affinity DataIC50: 9.10nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512328BDBM512328(Preparation of N-(4-fluoro-3-((2-((4-methoxyphenyl...)
Affinity DataIC50: 9.20nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512309BDBM512309(Preparation of N-(4-fluoro-3-((2-((1-isobutyl-1H-p...)
Affinity DataIC50: 9.60nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512313BDBM512313(Preparation of N-(3-((2-((benzo[d]thiazol-6-yl)ami...)
Affinity DataIC50: 9.80nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512305BDBM512305(Preparation of N-(3-((2-((1-ethyl-1H-pyrazol-4-yl)...)
Affinity DataIC50: 10nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512310BDBM512310(Preparation of N-(3-((2-((1-cyclopropyl-1H-pyrazol...)
Affinity DataIC50: 10.3nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Daewoong Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 512323BDBM512323(US11084823, Example 23)
Affinity DataIC50: 10.4nMAssay Description:Specifically, the inhibitory activities of JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase assay ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

Displayed 1 to 50 (of 100 total ) | Next | Last >>
Jump to: